Contact
searchSearch
HMP Global

Hidradenitis Suppurativa Topic Center

Featured

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
News
Increased Epigenetic Age May Be a Biomarker of Disease Burden in Hidradenitis Suppurativa
11/09/2022
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot...
11/09/2022
The Dermatologist

Q&As

Dr Amit Garg: Comorbidity Screening in HS
Q&As
Dr Amit Garg: Comorbidity Screening in HS
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
Q&As
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
04/24/2021
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD...
04/24/2021
The Dermatologist
The Who and When of Intralesional Injections for HS Treatment
Q&As
The Who and When of Intralesional Injections for HS Treatment
03/26/2021
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met...
03/26/2021
The Dermatologist
Brandon Adler, MD
Q&As
Insights Into Photoprotection Updates
02/08/2024
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the...
02/08/2024
The Dermatologist
Glynis Ablon
Q&As
Enhancing Appearance Procedures
02/04/2024
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon...
02/04/2024
The Dermatologist
Jonathan Silverberg, MD, PhD, MPH
Q&As
Revolutionizing Atopic Dermatitis: Virtual Sessions on Optimizing Patient Care
12/13/2023
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed...
12/13/2023
The Dermatologist
Elliott Campbell
Q&As
Gender Disparities and Advances in Cutaneous Melanoma
11/01/2023
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men. He delves into mortality disparities, discusses advances in treatment, and offers insights...
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men. He delves into mortality disparities, discusses advances in treatment, and offers insights...
In this interview, Dr Elliott...
11/01/2023
The Dermatologist
Ilka A. Netravali, MD, PhD, FAAD
Q&As
Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis
10/30/2023
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared...
10/30/2023
The Dermatologist
Jeremy Etzkorn-2019
Q&As
Nasal Function and Appearance Post Flap Repair: NAFEQ Study
09/26/2023
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn...
09/26/2023
The Dermatologist
Steven Feldman
Q&As
Advancing Psoriasis Patient Care
09/25/2023
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The...
09/25/2023
The Dermatologist
Derek Chu, MD, PhD, FRCPC
Q&As
Systemic and Topical Treatments For Atopic Dermatitis
09/20/2023
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview with...
09/20/2023
The Dermatologist
Emily Ruiz, MD, MPH
Q&As
Nonsurgical Approaches for Skin Cancer
09/12/2023
In this interview, Dr Emily Ruiz offers a glimpse into her upcoming session, “Nonsurgical Treatments for Skin Cancer,” at Dermatology Week Fall 2023.
In this interview, Dr Emily Ruiz offers a glimpse into her upcoming session, “Nonsurgical Treatments for Skin Cancer,” at Dermatology Week Fall 2023.
In this interview, Dr Emily Ruiz...
09/12/2023
The Dermatologist
Walayat Hussain, BSc, MBChB, MRCP, FRACP, FACMS
Q&As
Global Insights into Mohs Practice and Facial Reconstruction
09/06/2023
In this engaging interview, Dr Hussain discusses international variations in Mohs practice and shares insights from his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the 2023 American College of Mohs...
In this engaging interview, Dr Hussain discusses international variations in Mohs practice and shares insights from his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the 2023 American College of Mohs...
In this engaging interview, Dr...
09/06/2023
The Dermatologist

Multimedia

Dr Sherry Yang
Videos
Inflammation's Role in the Disease Progression of HS
11/17/2021
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the...
11/17/2021
The Dermatologist
Dr Sherry Yang
Videos
Demographics & Characteristics Associated With HS Diagnoses
11/12/2021
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient...
11/12/2021
The Dermatologist
Dr Sherry Yang
Videos
How to Approach HS Treatment
11/05/2021
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how...
11/05/2021
The Dermatologist
Videos
Clinical Implications of HS and Hepatitis B/C
06/10/2021
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical...
06/10/2021
The Dermatologist
Videos
Genetic Components and Hepatitis Risks in HS
06/10/2021
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr...
06/10/2021
The Dermatologist
Podcasts
Updates in HS: Dr Rosenblum on Pathophysiology
12/15/2020
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael...
12/15/2020
The Dermatologist
Podcasts
Dr Iltefat Hamzavi on Managing Hidradenitis Suppurativa
09/16/2020
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat...
09/16/2020
The Dermatologist
Dr Amy McMichael
Videos
The Complexities of Diagnosis and Assessment of Alopecia Areata
12/20/2024
In this video, Amy J McMichael, MD, FAAD, discusses the complexities of diagnosis with alopecia areata (eg, differential diagnosis), the currently available disease severity assessment tools, and the benefits and shortcomings of each tool and...
In this video, Amy J McMichael, MD, FAAD, discusses the complexities of diagnosis with alopecia areata (eg, differential diagnosis), the currently available disease severity assessment tools, and the benefits and shortcomings of each tool and...
In this video, Amy J McMichael,...
12/20/2024
The Dermatologist
Dr Brett King
Podcasts
Managing the Side Effects and Adherence of JAK Inhibitors for Patients With Severe Alopecia Areata
12/13/2024
In this podcast, Brett King, MD, PhD, discusses the use of JAK inhibitors for patients with severe alopecia areata and dives into how JAK inhibitors were discovered for the treatment of severe alopecia areata. He provides recommendations on...
In this podcast, Brett King, MD, PhD, discusses the use of JAK inhibitors for patients with severe alopecia areata and dives into how JAK inhibitors were discovered for the treatment of severe alopecia areata. He provides recommendations on...
In this podcast, Brett King, MD,...
12/13/2024
The Dermatologist
James Song
Videos
JAK Inhibitors in Treating Atopic Dermatitis
12/02/2024
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song...
12/02/2024
The Dermatologist
Gil Yosipovitch, MD,
Clinical Pearls
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology
Dr. Adam Friedman and Jaya Manjunath
Podcasts
The Elderderm: Episode 6, Combatting Barriers to Care For Elder Patients
10/16/2024
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration...
10/16/2024
The Dermatologist
Sadick
Videos
Innovations in Regenerative Medicine
09/12/2024
In this interview, Dr Sadick explores cutting-edge advancements in regenerative medicine, including PRP, exosomes, and cell banking, and their potential to revolutionize dermatology. Key insights are provided on emerging technologies and...
In this interview, Dr Sadick explores cutting-edge advancements in regenerative medicine, including PRP, exosomes, and cell banking, and their potential to revolutionize dermatology. Key insights are provided on emerging technologies and...
In this interview, Dr Sadick...
09/12/2024
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
06/21/2024
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
06/21/2024
The Dermatologist
Ramone F. Williams, MD, MPhil
Videos
Mohs Surgeons Leading the Future: Advancing Careers and Care
06/14/2024

Featuring Ramone F. Williams, MD, MPhil

Featuring Ramone F. Williams, MD, MPh...
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F....
06/14/2024
The Dermatologist

Quizzes

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Legs + Elbow + Knee
Quiz
Atopic Dermatitis and JAK Inhibitors
12/14/2024
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ...
12/14/2024
The Dermatologist
Illustration of JAK1 Protein
Quiz
Test Your Knowledge: The Immunology of JAK Inhibitors
12/05/2024
12/05/2024
The Dermatologist
Gil Yosipovitch, MD
Quiz
Long-Term Efficacy of Dupilumab for Prurigo Nodularis
12/05/2024
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed...
12/05/2024
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist

News

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
psoriatic arthritis
News
Defining Difficult-to-Treat Psoriatic Arthritis: A Scoping Review
01/07/2025
A recent scoping review highlights the challenges in defining and managing difficult-to-treat psoriatic arthritis.
A recent scoping review highlights the challenges in defining and managing difficult-to-treat psoriatic arthritis.
A recent scoping review...
01/07/2025
The Dermatologist
psoriasis
News
Study Links Psoriasis to Increased Dementia Risk
01/07/2025
A large population-based cohort study has identified a modestly increased risk of dementia in individuals with psoriasis.
A large population-based cohort study has identified a modestly increased risk of dementia in individuals with psoriasis.
A large population-based cohort...
01/07/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
psoriasis
News
Sarcopenia and Osteoporosis: Overlapping Risks in Patients With Psoriatic Arthritis
12/25/2024
A study uncovers the prevalence of sarcopenia and osteoporosis in patients with PsA, emphasizing the interconnected role of body composition and bone health.
A study uncovers the prevalence of sarcopenia and osteoporosis in patients with PsA, emphasizing the interconnected role of body composition and bone health.
A study uncovers the prevalence...
12/25/2024
The Dermatologist
Atopic dermatitis
News
Tobacco Smoke Exposure Unlikely to Worsen Atopic Dermatitis in Youth
12/23/2024
A comprehensive study finds no significant link between exposure to tobacco smoke and the severity or activity of atopic dermatitis in children and adolescents.
A comprehensive study finds no significant link between exposure to tobacco smoke and the severity or activity of atopic dermatitis in children and adolescents.
A comprehensive study finds no...
12/23/2024
The Dermatologist
family
News
Childhood Psoriasis: Emotional Toll on Families During Adolescence
12/20/2024
A new study reveals how childhood psoriasis affects both children and their parents during the turbulent transition to adolescence, emphasizing the need for systemic psychological support.
A new study reveals how childhood psoriasis affects both children and their parents during the turbulent transition to adolescence, emphasizing the need for systemic psychological support.
A new study reveals how...
12/20/2024
The Dermatologist
Atopic dermatitis
News
Mulberry Extract Shows Promise in Treating Atopic Dermatitis
12/18/2024
A traditional remedy, white mulberry demonstrates therapeutic potential for eczema, offering a natural alternative to chemical treatments.
A traditional remedy, white mulberry demonstrates therapeutic potential for eczema, offering a natural alternative to chemical treatments.
A traditional remedy, white...
12/18/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Tapinarof Cream 1% for Atopic Dermatitis in Adults and Children
12/16/2024
Organon’s VTAMA cream, 1%, offers a steroid-free solution for patients 2 years and older with moderate-to-severe atopic dermatitis, featuring powerful skin clearance and rapid itch relief.
Organon’s VTAMA cream, 1%, offers a steroid-free solution for patients 2 years and older with moderate-to-severe atopic dermatitis, featuring powerful skin clearance and rapid itch relief.
Organon’s VTAMA cream, 1%,...
12/16/2024
The Dermatologist
Nov/Dec 2024 Cover

Current Issue

December 2024
Volume 32
Issue 8
Current Issue
Issue Archive

Popular Articles

Positive Phase III Data for Advanced Melanoma Treatment
10/20/2014
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from...
10/20/2014
The Dermatologist
Chief Medical Editor Message
Navigating the Turbulent Health Care System
04/18/2017
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party...
04/18/2017
The Dermatologist
The Relevance of Vehicle in Low-Potency Topical Steroids: 2 Case Studies of Pruritic Condition
07/25/2014
07/25/2014
The Dermatologist
News
Psoriasis Treatment Improves Skin Clearance in Biologic Naïve Patients
03/14/2017
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque...
03/14/2017
The Dermatologist
New Topical Onychomycosis Treatment Approved
06/13/2014
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical...
06/13/2014
The Dermatologist

Subscribe

The Dermatologist Newsletter

Latest Quizzes and Trivia

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Legs + Elbow + Knee
Quiz
Atopic Dermatitis and JAK Inhibitors
12/14/2024
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ...
12/14/2024
The Dermatologist
Illustration of JAK1 Protein
Quiz
Test Your Knowledge: The Immunology of JAK Inhibitors
12/05/2024
12/05/2024
The Dermatologist
Gil Yosipovitch, MD
Quiz
Long-Term Efficacy of Dupilumab for Prurigo Nodularis
12/05/2024
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed...
12/05/2024
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use